These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

74 related items for PubMed ID: 1305588

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Effect of estrogens on pharmacokinetics of phenazone and N-acetyl-p-aminophenol].
    Kwiatkowski A.
    Ann Acad Med Stetin; 1991; 37():35-47. PubMed ID: 1816754
    [Abstract] [Full Text] [Related]

  • 3. [Pharmacokinetics of paracetamol after removal of ovaries in rabbits].
    Kwiatkowski A, Gawrońska-Szklarz B, Droździk M, Wójcicki J.
    Endokrynol Pol; 1993; 44(1):73-9. PubMed ID: 8050393
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics of phenazone (antipyrine) in rabbits with experimental common bile duct obstruction.
    Wójcicki J, Sulikowski T, Wójcicki M, Droździk M, Gawrońska-Szklarz B, Barcew-Wiszniewska B, Skowron J, Rózewicka L.
    Br J Pharmacol; 1996 Jan; 117(1):1-4. PubMed ID: 8825335
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The relationship between phenazone (antipyrine) metabolite formation and theophylline metabolism in healthy and frail elderly women.
    Groen K, Horan MA, Roberts NA, Gulati RS, Miljkovic B, Jansen EJ, Paramsothy V, Breimer DD, van Bezooijen CF.
    Clin Pharmacokinet; 1993 Aug; 25(2):136-44. PubMed ID: 8403737
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effect of schistosomiasis infection on the clearance of phenazone in mice.
    Metwally AA, Janku I, Kemper F, Khayyal MT, Ebeid FA, Botros SS.
    Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):206-9. PubMed ID: 2110459
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The influence of propranolol and glucagon on the pharmacokinetics of antipyrine and sodium salicylate.
    Orszulak-Michalak D, Kaszubski P.
    Pharmazie; 1987 Jun; 42(6):394-6. PubMed ID: 3671460
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of mestranol on pharmacokinetics of paracetamol.
    Droździk M, Kwiatkowski A, Wójcicki J, Gawrońska-Szklarz B.
    Acta Pol Pharm; 1994 Jun; 51(2):175-8. PubMed ID: 7863788
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effect of some anti-cancer drugs and combined chemotherapy on the pharmacokinetics of antipyrine in the rat.
    Skretkowicz J.
    Pol J Pharmacol; 1995 Jun; 47(6):519-24. PubMed ID: 8868374
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.